# Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)

> **NCT04427280** · — · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 153 (actual)

## Conditions studied

- Infectious Disease
- Cancer
- Coronavirus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Throat/nose swabs
- **DIAGNOSTIC_TEST:** Saliva collection
- **DIAGNOSTIC_TEST:** Blood collection

## Key facts

- **NCT ID:** NCT04427280
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-26
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-06-29
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2025-09-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04427280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04427280, "Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04427280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*